beta-Catenin/TCF/LEF1 can directly regulate phenylephrine-induced cell hypertrophy and Anf transcription in cardiomyocytes

Biochem Biophys Res Commun. 2009 Dec 11;390(2):258-62. doi: 10.1016/j.bbrc.2009.09.101. Epub 2009 Sep 30.

Abstract

beta-Catenin/TCF/LEF1 signaling is implicated in cardiac hypertrophy. We demonstrate that knockdown of beta-catenin attenuates phenylephrine (PE)-induced cardiomyocyte hypertrophy and the up-regulation of the fetal gene Anf. We explore the mechanism through which beta-catenin regulates Anf expression and find a consensus binding sequence on the Anf promoter for TCF/LEF1 family members. LEF1 binds directly to the Anf promoter via this sequence, which shows functional significance, and PE stimulation enhances recruitment of beta-catenin onto the Anf promoter. Thus, we document a direct positive role of beta-catenin on PE-induced cardiomyocyte hypertrophy and identify a new target gene for beta-catenin/TCF/LEF1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Atrial Natriuretic Factor / genetics*
  • Cardiomegaly / chemically induced
  • Cardiomegaly / genetics
  • Cardiomegaly / metabolism*
  • Gene Expression Regulation*
  • Gene Knockdown Techniques
  • Lymphoid Enhancer-Binding Factor 1 / metabolism
  • Myocytes, Cardiac / drug effects
  • Myocytes, Cardiac / metabolism*
  • Phenylephrine / pharmacology
  • Promoter Regions, Genetic
  • Rats
  • Rats, Sprague-Dawley
  • TCF Transcription Factors / metabolism
  • Transcription, Genetic
  • Up-Regulation
  • beta Catenin / genetics
  • beta Catenin / metabolism*

Substances

  • Lef1 protein, rat
  • Lymphoid Enhancer-Binding Factor 1
  • TCF Transcription Factors
  • beta Catenin
  • Phenylephrine
  • Atrial Natriuretic Factor